106 related articles for article (PubMed ID: 30356023)
1. Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis.
Chang CC; Su KM; Lu KH; Lin CK; Wang PH; Li HY; Wang ML; Lin CK; Yu MH; Chang CM
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30356023
[TBL] [Abstract][Full Text] [Related]
2. The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis.
Su KM; Lin TW; Liu LC; Yang YP; Wang ML; Tsai PH; Wang PH; Yu MH; Chang CM; Chang CC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316695
[TBL] [Abstract][Full Text] [Related]
3. Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages.
Chang CM; Chuang CM; Wang ML; Yang MJ; Chang CC; Yen MS; Chiou SH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275818
[TBL] [Abstract][Full Text] [Related]
4. Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer.
Chang CM; Chuang CM; Wang ML; Yang YP; Chuang JH; Yang MJ; Yen MS; Chiou SH; Chang CC
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527159
[TBL] [Abstract][Full Text] [Related]
5. Gene set-based analysis of mucinous ovarian carcinoma.
Chang CM; Wang PH; Horng HC
Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract][Full Text] [Related]
7. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
[TBL] [Abstract][Full Text] [Related]
8. Gene set-based integrative analysis of ovarian clear cell carcinoma.
Chang CM; Chiou SH; Yang MJ; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):552-7. PubMed ID: 27590381
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study.
Calura E; Ciciani M; Sambugaro A; Paracchini L; Benvenuto G; Milite S; Martini P; Beltrame L; Zane F; Fruscio R; Marchette MD; Borella F; Tognon G; Ravaggi A; Katsaros D; Bignotti E; Odicino F; D'Incalci M; Marchini S; Romualdi C
Cells; 2019 Dec; 8(12):. PubMed ID: 31805750
[TBL] [Abstract][Full Text] [Related]
10. Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer.
Desbois M; Udyavar AR; Ryner L; Kozlowski C; Guan Y; Dürrbaum M; Lu S; Fortin JP; Koeppen H; Ziai J; Chang CW; Keerthivasan S; Plante M; Bourgon R; Bais C; Hegde P; Daemen A; Turley S; Wang Y
Nat Commun; 2020 Nov; 11(1):5583. PubMed ID: 33149148
[TBL] [Abstract][Full Text] [Related]
11. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated immunological and metabolic functions discovered by a polygenic integrative analysis for PCOS.
Ho CH; Chang CM; Li HY; Shen HY; Lieu FK; Wang PS
Reprod Biomed Online; 2020 Jan; 40(1):160-167. PubMed ID: 31780352
[TBL] [Abstract][Full Text] [Related]
13. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
15. EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.
Rattanapan Y; Korkiatsakul V; Kongruang A; Chareonsirisuthigul T; Rerkamnuaychoke B; Wongkularb A; Wilailak S
Cancer Genet; 2018 Aug; 224-225():37-40. PubMed ID: 29778234
[TBL] [Abstract][Full Text] [Related]
16. Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer.
Richardson DL; Seward SM; Moore KN
Hematol Oncol Clin North Am; 2018 Dec; 32(6):1057-1071. PubMed ID: 30390760
[TBL] [Abstract][Full Text] [Related]
17. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
[TBL] [Abstract][Full Text] [Related]
18. Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
Liew PL; Huang RL; Weng YC; Fang CL; Hui-Ming Huang T; Lai HC
Int J Cancer; 2018 Jul; 143(2):355-367. PubMed ID: 29451304
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
[TBL] [Abstract][Full Text] [Related]
20. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]